- Gender Specific Aspects of Cell Death in the Cardiovascular System
[作者:Pierdominici, M; Ortona, E; Franconi, F; Caprio, M; Straface, E; Malorni, W,期刊:Current Pharmaceutical Design, 页码:1046-1055 , 文章类型: Review,,卷期:2011年17-11]
- It has become apparent over the past few decades that several factors can determine lethal or sublethal alterations of cardiovascular system cell function such as inflammatory reaction products, peptides and hormones. In...
- Gender Differences in the Treatment of Ischemic Heart Disease
[作者:Barylski, M; Mikhailidis, DP; Ciebiada, M; Rysz, J; Banach, M,期刊:Current Pharmaceutical Design, 页码:1059-1069 , 文章类型: Review,,卷期:2011年17-11]
- Ischemic heart disease (IHD) is a leading cause of mortality and morbidity in most developed countries. Many studies revealed gender differences in the presentation, prevalence, and clinical outcomes of IHD. Compared wit...
- Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
[作者:Mercuro, G; Deidda, M; Bina, A; Manconi, E; Rosano, GMC,期刊:Current Pharmaceutical Design, 页码:1082-1089 , 文章类型: Review,,卷期:2011年17-11]
- Gender differences in biological substrates of disease determine different clinical manifestations of CV disease with important implications for prevention, diagnosis and therapy in the two sexes.In women, the activity o...
- Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease
[作者:Yoshida, H; Rosano, G; Shimizu, M; Mochizuki, S; Yoshimura, M,期刊:Current Pharmaceutical Design, 页码:1090-1094 , 文章类型: Review,,卷期:2011年17-11]
- Women tend to develop hypertension later as they transition into menopause, and during and after menopause the development of hypertension in women is independent of age and body mass index (BMI) but is related to menopa...
- The Effect of SEX/Gender on Cardiovascular Pharmacology
[作者:Franconi, F; Carru, C; Malorni, W; Vella, S; Mercuro, G,期刊:Current Pharmaceutical Design, 页码:1095-1107 , 文章类型: Review,,卷期:2011年17-11]
- Cardiovascular diseases differ between men and women as do outcomes after therapeutic interventions. Management of these diseases, however, is generally guided by evidence from trials conducted predominantly in men, with...
- Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
[作者:Vaidya, A; Agarwal, A; Jain, A; Agrawal, RK; Jain, SK,期刊:Current Pharmaceutical Design, 页码:1108-1125 , 文章类型: Review,,卷期:2011年17-11]
- Bioconjugation, a novel technique is usually exploited to improve the biopharmaceutical aspects of a bioactive as well as afford its spatial and temporal distribution. The strategy enlightens newer vistas for delivery of...
|